Status:
COMPLETED
NOVA22007 0.05% and 0.1% Cyclosporine Versus Vehicle for the Treatment of Dry Eye
Lead Sponsor:
Santen SAS
Conditions:
Dry Eye
Eligibility:
All Genders
18+ years
Phase:
PHASE2
Brief Summary
Study is to assess the safety and efficacy of NOVA22007 0.05% and 0.1% Cyclosporine Ophthalmic Cationic Emulsions QD compared to vehicle for the treatment of the signs and symptoms of dry eye after a ...
Eligibility Criteria
Inclusion
- Male and female 18 years and older
- Diagnosis of dry eye in both eyes
Exclusion
- Contraindications to the use of the study medications
- Known allergy or sensitivity to the study medications or their components
- Female currently pregnant, nursing, or planning a pregnancy; or woman who has a positive pregnancy test
- Have participated in an investigational drug or device study within 30 days of Visit 1
Key Trial Info
Start Date :
August 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 1 2009
Estimated Enrollment :
132 Patients enrolled
Trial Details
Trial ID
NCT00739349
Start Date
August 1 2008
End Date
January 1 2009
Last Update
June 6 2016
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Central Maine Eye Care, PA
Lewiston, Maine, United States, 04240